|
|
|||
| |||||||||||||||||||||||||||||||||
An article featured in the January 17, 2001, business section of the New York Times, "When Gene Sequencing Becomes a Fact of Life" by Andrew Pollack, reported the development of a new way to sequence the genes of the human immunodeficiency virus. This genetic test, its owners claim, will "help doctors choose which of the 15 or so available drugs will work best against a particular patient's infection." Although the value of the test is unsettled, the announcement underscores the way in which molecular genetics is going to change clinical medicine. Physicians who doubt that gene-based medicine will soon influence
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |